---
figid: PMC9120690__NRR-17-2427-g001
figtitle: Targeting O-GlcNAcylation in ischemic stroke
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
pmcid: PMC9120690
filename: NRR-17-2427-g001.jpg
figlink: /pmc/articles/PMC9120690/figure/F1/
number: F1
caption: 'The XBP1s/HBP/O-GlcNAc axis.Activated IRE1 splices Xbp1 mRNA, which is then
  translated into XBP1s protein. XBP1s, a transcriptional factor, can upregulate the
  expression of HBP enzymes, including GFAT (*, the rate-limiting enzyme of HBP).
  The HBP produces UDP-GlcNAc, which is the sugar donor for O-GlcNAcylation, a post-translational
  modification. Glucosamine and thiamet-G have been used to pharmacologically increase
  O-GlcNAcylation. ER: Endoplasmic reticulum; GFAT: glutamine fructose-6-phosphate
  aminotransferase; GNK: GlcNAc kinase; GNPNAT1: glucosamine-phosphate N-acetyltransferase
  1; HBP: hexosamine biosynthetic pathway; IRE1: inositol-requiring enzyme 1; OGA:
  O-GlcNAcase; OGT: O-GlcNAc transferase; PGM3: phosphoglucomutase 3; UDP-GlcNAc:
  uridine diphosphate N-acetylglucosamine.'
papertitle: Targeting O-GlcNAcylation in ischemic stroke.
reftext: Xuan Li, et al. Neural Regen Res. 2022 Nov;17(11):2427-2428.
year: '2022'
doi: 10.4103/1673-5374.335806
journal_title: Neural Regeneration Research
journal_nlm_ta: Neural Regen Res
publisher_name: Wolters Kluwer - Medknow
keywords: ''
automl_pathway: 0.9547797
figid_alias: PMC9120690__F1
figtype: Figure
organisms_ner:
- Homo sapiens
- Mus musculus
- Rattus norvegicus
redirect_from: /figures/PMC9120690__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9120690__NRR-17-2427-g001.html
  '@type': Dataset
  description: 'The XBP1s/HBP/O-GlcNAc axis.Activated IRE1 splices Xbp1 mRNA, which
    is then translated into XBP1s protein. XBP1s, a transcriptional factor, can upregulate
    the expression of HBP enzymes, including GFAT (*, the rate-limiting enzyme of
    HBP). The HBP produces UDP-GlcNAc, which is the sugar donor for O-GlcNAcylation,
    a post-translational modification. Glucosamine and thiamet-G have been used to
    pharmacologically increase O-GlcNAcylation. ER: Endoplasmic reticulum; GFAT: glutamine
    fructose-6-phosphate aminotransferase; GNK: GlcNAc kinase; GNPNAT1: glucosamine-phosphate
    N-acetyltransferase 1; HBP: hexosamine biosynthetic pathway; IRE1: inositol-requiring
    enzyme 1; OGA: O-GlcNAcase; OGT: O-GlcNAc transferase; PGM3: phosphoglucomutase
    3; UDP-GlcNAc: uridine diphosphate N-acetylglucosamine.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ERN1
  - XBP1
  - XBP1P1
  - AZU1
  - HDLBP
  - SLBP
  - STAM2
  - HEBP1
  - GFPT1
  - GFPT2
  - GNPNAT1
  - PGM3
  - NAGK
  - OGA
  - OGT
  - EOGT
  - POMGNT1
  - POMGNT2
  - Ern2
  - Xbp1
  - Stam2
  - Gfpt1
  - Gnpnat1
  - Pgm3
  - Nagk
  - Oga
  - Ogt
---
